Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease acute promyelocytic leukemia
Comorbidity C0035078|renal failure
Sentences 3
PubMedID- 21656902 Arsenic trioxide for the treatment of a relapsed acute promyelocytic leukemia with acute renal failure.
PubMedID- 23078653 Conclusion: arsenic trioxide can be used safely and effectively to treat acute promyelocytic leukemia in patients with advanced renal failure using careful monitoring of side effects rather than blood levels of arsenic to guide therapeutic dosing.
PubMedID- 25600167 Objective: to determine the potential for arsenic trioxide (ato) to be safely and effectively incorporated into induction therapy of newly diagnosed acute promyelocytic leukaemia (apl) in patients with severe chronic renal failure (crf) by reduction of the ato dosage to compensate for reduced renal elimination of arsenic in crf.

Page: 1